N6-methyladenosine (m6A) serves as a critical RNA modification, dynamically governing RNA metabolism through its influence on RNA stability, splicing, ...

Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.

A Ludwig Cancer Research study has identified a complex chain of molecular chatter by which cancer cells, exploiting ordinary ...

Controlling the activity of specific genes in the laboratory through the editing of their epigenetic marks is now a reality ...

Controlling the activity of specific genes in the laboratory through the editing of their epigenetic marks is now a reality thanks to the CRISPR technology. A team from the Josep Carreras Leukaemia ...

Amino acids play a fundamental role in regulating how cells respond to drugs. These molecules, which form proteins, act like ...

The brain fog that can linger after a bout with COVID is not a new discovery. In fact, much research has linked this long-COVID symptom to the neuroinflammation that often accompanies an infection.

When a pathogen is detected, the CNLs and RNLs respond by forming multiprotein complexes known as resistosomes, which act as ...

In a landmark study, researchers from Korea University have discovered a surprising answer: the protein WEE1, traditionally known as a cell cycle regulator and tumor suppressor, can paradoxically ...

Cats with a severe coronavirus disease experienced an immune system boost after treatment with an MSC therapy, opening translational avenues for humans.

The FDA has loosened safety restrictions for six CAR T-cell immunotherapies, used in treating a number of blood cancers.

Recently, a research team from Chongqing Medical University, led by Prof. Wei Huang, Dr. Wei Bao, and Dr. Yiting Lei, has successfully developed a novel engineered extracellular matrix (eECM) to ...